An interventional study of Full Plate Living Nutrition Education Program in Diabetes Mellitus, Pre Diabetes and Obesity, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to participants aged 22 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Diabetes Mellitus by University of Wisconsin, Madison — 3 open to participants now, 3 under way, none of them phase 3. Diabetes Mellitus · University of Wisconsin, Madison.
Among the 18 studies in Diabetes Mellitus by University of Wisconsin, Madison, this one is the 5th largest by enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2026, is one of 10 with no phase, and was the 17th registered.
8,295 studies on the registry are indexed under Diabetes Mellitus; 1,071 are open to participants now.
Browse Diabetes Mellitus studies →3 of the 18 studies in Diabetes Mellitus by University of Wisconsin, Madison are open now, in 1 country. Recruiting first, the newest first:
University of Wisconsin, Madison · Sites in United States
Ages 22+
University of Wisconsin, Madison · Sites in United States
Ages 18–90
University of Wisconsin, Madison · Sites in United States
Ages 22+ · Healthy volunteers
By country, each count listing its studies:
Of the 649 Diabetes Mellitus studies recruiting now, 358 (55%) set no upper age limit and 194 (30%) stop at 75 or younger; 89 take children under 18; 181 take healthy volunteers.
This study: 22 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 1999; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 42 is below the median of 80 across 6,027 interventional studies indexed under Diabetes Mellitus.
Median enrollment 32 across the 12 interventional studies, 258 across the 4 observational. Of the 14 that completed or were terminated, 2 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Wisconsin, Madison is the lead sponsor of 1,190 studies on the registry; 181 are open to participants now.
Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.
1 of the studies in Diabetes Mellitus by University of Wisconsin, Madison that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07559292University of Wisconsin, MadisonImplementing Artificial Intelligence to Prevent Vision Loss From Diabetes | 2027-02 |
Add it to your calendar (.ics) → With an account.
Among the 18 studies in Diabetes Mellitus by University of Wisconsin, Madison, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of the research is to evaluate the acceptability and feasibility of implementing a 8-session nutritional education program in a general internal medicine clinic. This program emphasizes a fiber-rich, whole foods diet consisting of fruits, vegetables, legumes, whole grains, nuts and seeds. Such interventions can improve diabetes management and lead to weight loss. 48 participants will be enrolled and on study for approximately 5 months.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Full Plate Living Nutrition Education Program
Participants will attend 8 sessions over 8 weeks. Participants will learn about the importance of fiber and how to add fiber to their diet.
Participant Weight
Time frame: retrospectively from 2 years prior to enrollment and up to 20 weeks on study (3 month follow up)
Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24)
Dietary fiber (grams per day) will be measured using the Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) which has been validated for measuring fiber intake in adults. The ASA24 is a free, web-based tool. Participants will complete the ASA24 online two times prior to the first session, 2 times prior to the last session, and 2 times 3 months after the last session.
Time frame: baseline, 8 weeks, 20 weeks (3 month follow up)
Participant Quality of Life measured by the SF-12 score
Possible scores range from 0-100 with higher scores indicating better quality of life.
Time frame: baseline, 8 weeks, 20 weeks (3 month follow up)
Acceptability: Percent of Participants who found the intervention acceptable
A subset of participants will be invited to complete an individual interview after the last session. The aim is to schedule 8-12 participants for interviews including both participants who completed all the sessions and those stopped attending sessions. Data will be derived from these qualitative semi-structured interviews.
Time frame: Participant surveyed at the end of last session, approximately 8 weeks
Feasibility: Participant Retention Rate
Feasibility will in part be measured by participant retention rate, the number of participants who complete each time point of data collection over the number of participants enrolled.
Time frame: baseline, 8 weeks, 20 weeks (3 month follow up)
Feasibility: Participation Rate
Feasibility will in part be measured by participation rate, the number of participants enrolled over the target enrollment.
Time frame: Through enrollment (up to 3 months)
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Jan 2026 to primary completion in Sep 2026, 7 months.
Of 1,590 non-industry interventional studies with no phase under Diabetes Mellitus, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 7 months is below that.
Counting every sponsor, half of 1,750 studies reached it within 21 months; a quarter within 9 and three quarters within 42.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jan 2027 → Sep 2026 and completion Jan 2027 → Sep 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Wisconsin, Madison →